Protocol of a randomized trial of acceptance and commitment therapy for fatigue interference in metastatic breast cancer.

ABSTRACT: Fatigue interference with activities, mood, and cognition is one of the most prevalent and distressing concerns of metastatic breast cancer patients. To date, there are no evidence-based interventions for reducing fatigue interference in metastatic breast cancer and other advanced cancer populations. In pilot studies, Acceptance and Commitment Therapy (ACT) has shown potential for reducing symptom-related suffering in cancer patients. The current Phase II trial seeks to more definitively examine the efficacy of telephone-based ACT for women with metastatic breast cancer who are experiencing fatigue interference. In this trial, 250 women are randomly assigned to either the ACT intervention or an education/support control condition. Women in both conditions attend six weekly 50-min telephone

SUBMITTER: Mosher CE 

PROVIDER: S-EPMC7686157 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature